Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review
- 17 May 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 19 (6) , 545-555
Abstract
Introduction: Glioblastoma multiforme (GBM) has a poor prognosis despite maximal surgical resection with subsequent multi-modal radiation and chemotherapy. Use of tobacco products following diagnosis and during the period of treatment for non-neural tumors detrimentally affects treatment and prognosis. 16-28% of patients with glioblastoma continue to smoke after diagnosis and during treatment. The literature is sparse for information pertaining effects of smoking and nicotine on GBM treatment and prognosis. Areas covered: This review discusses cellular pathways involved in GBM progression that might be affected by nicotine, as well as how nicotine may contribute to resistance to treatment. Similarities of GBM pathways to those in non-neural tumors are investigated for potential effects by nicotine. English language papers were identified using PubMed, Medline and Scopus databases using a combination of keywords including but not limited to the following: nicotine, vaping, tobacco, e-cigarettes, smoking, vaping AND glioblastoma or brain cancer OR/AND temozolomide, carmustine, methotrexate, procarbazine, lomustine, vincristine, and neural tumor cell lines. Expert Opinion: Understanding the impact of nicotine on treatment and resistance to chemotherapeutics should allow physicians to educate their patients with GBM with evidence-based recommendations about the effects of continuing to use nicotine-containing products after diagnosis and during treatment.Keywords
Funding Information
- Head for the Cure (N/A)
This publication has 106 references indexed in Scilit:
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide eraJournal of Neuro-Oncology, 2011
- Associations of High-Grade Glioma With Glioma Risk Alleles and Histories of Allergy and SmokingAmerican Journal of Epidemiology, 2011
- Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretroviralsLife Sciences, 2011
- β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma CellsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer ChemotherapyMetal-Based Drugs, 2010
- Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell linesInternational Journal of Cancer, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivinProceedings of the National Academy of Sciences, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005